EUCAST News
Here you can find the latest news and updates from EUCAST.
Proposed change of breakpoints for aminopenicillins in enterococci
Proposed change of breakpoints for aminopenicillins in enterococci (consultation period 7 May - 14 June, 2024). Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the...[more]
Consultation: benzylpenicillin breakpoints for S.pneumoniae and Viridans group streptococci
EUCAST consultation(3 May - 14 June) on breakpoints for Streptococcus pneumoniae and viridans group streptococci. [more]
Aztreonam-avibactam and cefepime-enmetazobactam now available.
Aztreonam-avibactamhas now obtained regulatory approval and breakpoints from EMA and EUCAST for Enterobacterales. These are S≤4, R>4 mg/L.Disk diffusion criteria and QC targets and ranges will be published...[more]
Salmonella enterica - multinational zone diameter distributions uploaded
Salmonella entericazone diameter distributions and ECOFFs for thousands of isolates from many countries were uploaded. The contributions were organised through an ECDC project using phenotypic antimicrobial...[more]
Information for industry - reference and standardised AST.
EUCAST guidance on how to determine MIC values and develop distributions (and zone diameter distributions) for new agents in preparation for EUCAST and EMA evaluation. The development of new agents requires agreement and...[more]
Warning against the use of AST devices for amphotericin B testing of Candida auris.
The Warning pertains to the following AST methods for amphotericin B and C. auris. Etest, (Etest, bioMerieux), gradient strip Mic Test Strip (MTS,Liofilchem),gradient strip Vitek 2 system...[more]
Dalbavancin MIC distributions and ECOFFs
Dalbavancin MIC distributions and ECOFFs, particularly for Enterococcus faecalis and E. faecium, made available. This is in response to frequent requests for more information on dalbavancin MIC distributions. [more]
